Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Condition: Mantle Cell Lymphoma Interventions: Drug: Zanubrutinib; Biological: Rituximab; Other: Patient Observation; Procedure: Bone Marrow Biopsy; Other: Fludeoxyglucose F-18; Procedure: Positron Emission Tomography; Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging; Procedure: Esophagogastroduodenoscopy; Procedure: Colonoscopy; Procedure: Biospecimen Collection; Other: Questionnaire Administration Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Colonoscopy | Esophagogastroduodenoscopy | Lymphoma | Panendoscopy | Research | Rituxan | Study